Author

Balaji Dashrath Sathe

Observed name: Balaji D. Sathe

Observed institutions: University of Mumbai, Bharatiya Vidya Bhavan

OpenAlex ID: A5114869331

Design, synthesis and optimization of bis-amide derivatives as CSF1R inhibitors

2017 · Sreekanth A. Ramachandran, Pradeep S. Jadhavar, et al. · Bioorganic & Medicinal Chemistry Letters · 18

Targeting prostate cancer with compounds possessing dual activity as androgen receptor antagonists and HDAC6 inhibitors

2016 · Pradeep S. Jadhavar, Sreekanth A. Ramachandran, et al. · Bioorganic & Medicinal Chemistry Letters · 17

Design and Development of Novel Hybrids Based on Pyrrolo[2,1‐ f ][1,2,4]Triazine and 1‐(Methylpiperidin‐4‐yl) Aniline–Based Analogs: Exploring the Utility as Anticancer Agents via MERTK Inhibition

2024 · Balaji Dashrath Sathe, Shivani Jaiswal, et al. · Chemical Biology & Drug Design · 3

Dual inhibition of AXL and MER kinase: scope for lung and breast cancer therapeutics

2025 · Balaji Dashrath Sathe, Pratibha Kumari, et al. · Bioorganic Chemistry

Development of New N-{4-[(7-Chloro-5-methylpyrrolo[2,1-f] [1,2,4]triazin-4-yl)oxy]-3-fluorophenyl}benzenesulfonamide Analogues: Exploring Anticancer Potential through MerTK Inhibition

2024 · Ashish Ranjan Dwivedi, S. V. Rathod, et al. · Synlett

Abstract 5465: Discovery of LXRβ selective agonists promote immune cell activation and induce tumor growth inhibition in syngeneic tumor model

2022 · Brahmam Pujala, Balaji Dashrath Sathe, et al. · Cancer Research

Works count: 6

Citation count: 38

H-index: 3

I10-index: 2